In humans, embryonic cell compaction is a crucial step in the normal development of an embryo. Four days after fertilisation, cells move closer together to give the embryo its initial shape. Defective compaction prevents the formation of the structure that ensures the embryo can implant in the uterus. In assisted reproductive technology (ART), this stage is carefully monitored before an embryo is implanted.
An interdisciplinary research team1 led by scientists at the Genetics and Developmental Biology Unit at the Institut Curie (CNRS/Inserm/Institut Curie) studying the mechanisms at play in this still little-known phenomenon has made a surprising discovery: human embryo compaction is driven by the contraction of embryonic cells. Compaction problems are therefore due to faulty contractility in these cells, and not a lack of adhesion between them, as was previously assumed. This mechanism had already been identified in flies, zebrafish and mice, but is a first in humans.
By improving our understanding of the early stages of human embryonic development, the research team hopes to contribute to the refinement of ART as nearly one third of inseminations are unsuccessful today.2
The results were obtained by mapping cell surface tensions in human embryonic cells. The scientists also tested the effects of inhibiting contractility and cell adhesion and analysed the mechanical signature of embryonic cells with defective contractility.
Notes : 1 — Scientists from the following entities also took part in the study: the Centre interdisciplinaire de recherche en biologie (CNRS/Collège de France/Inserm), the Reproductive Biology Department — CECOS (AP-HP) and the Institut Cochin (CNRS/Inserm/Université Paris Cité).
2 — Source: Agence de la biomédecine
Source link
